No Data
No Data
Korro Announces Addition of Industry Veteran Katharine Knobil to and Resignation of David Lucchino From Its Board of Directors
Marker Therapeutics GAAP EPS of -$0.25 Beats by $0.24, Revenue of $1.17M
Marker Therapeutics Excels in Lymphoma Treatment Study
Marker Therapeutics | 10-Q: Q2 2024 Earnings Report
Earnings Flash (MRKR) MARKER THERAPEUTICS Reports Q2 Revenue $1.2M
Express News | Marker Therapeutics Inc - Qtrly Net Loss per Share $0.25
No Data
No Data